StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$941.25−6.27 (-0.66%)

Close on Nov 18, 2026Market cap –P/E 48.1Yield –

argenx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was $35.53M, up 254.4% from the year before. The highest annual figure on record is $497.28M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$35.53M+254.4%
FY2022Dec 31, 2022$10.03M-98.0%
FY2021Dec 31, 2021$497.28M+1105.7%
FY2020Dec 31, 2020$41.24M-47.4%
FY2019Dec 31, 2019$78.46M+265.2%
FY2018Dec 31, 2018$21.48M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2022Jun 30, 2022$96.00M–

More argenx figures

See a number that looks wrong?